It establishes, for the first time, the dual role of CuET in stimulating NKG2D activating receptor expression in NK and T lymphocytes, and its effect on corresponding ligands in tumor cells, bolstering anticancer cytotoxicity. This evidence concerns the gene KLRK1 and neoplasm.